Voltar
Artigo Revisado por pares
BIBTEX RIS

Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects

2004; Springer Science+Business Media; Volume: 23; Issue: 1 Linguagem: Inglês

10.1023/b

ISSN

1573-0646

Autores

Aimee K. Bence, Eric B. Anderson, Maqbool Halepota, Michael Doukas, Phillip A. DeSimone, George A. Davis, Deborah A. Smith, Kevin M. Koch, Andrew G. Stead, Steve Mangum, Carolyn J. Bowen, Neil L. Spector, Showchien Hsieh, Val R. Adams,

Tópico(s)

Lung Cancer Treatments and Mutations

Referência(s)